Lung

Most recent

Other

CamBMT1: a proof-of-principle phase Ib/randomized phase II study of afatinib penetration into brain metastases for patients undergoing neurosurgical resection, both with and without prior low-dose, targeted radiotherapy

Baird RD, et al. ESMO 2016:1318 Background Brain metastases occur in 20–40% of all patients with cancer, and 30–50% of patients with locally advanced non-small cell lung cancer will relapse in the central nervous system. Failure of drugs to cross the blood-brain...

Twitter feed

Already looking forward to #ASH19 ? The NE Live Team has you covered until then. Catch up on perspectives captured… https://t.co/TPVZDwe1nc
h J R
Unable to attend #ASH18 ? NE Live was on site to capture up-to-the-minute perspectives on pivitol research. Visit… https://t.co/hyGWk82vqo
h J R
Watch the NE Live team discuss The GRIFFIN Study in Patients with Newly Diagnosed Multiple Myeloma Eligible for HDT… https://t.co/bIY5TzmT9L
h J R
The NE Live team caught up with Dr. Laurie Sehn on day 2 of #ASH18 to discuss The AUGMENT Study with Lenalidomide a… https://t.co/vE7NnCBL40
h J R